IC
CHRS icon

IEQ Capital’s Coherus Oncology CHRS Stock Holding History

IEQ Capital’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$206K Buy
121,967
+42,839
+54% +$76.1K ﹤0.01% 1690
2025
Q4 		$112K Buy
79,128
+15,751
+25% +$23K ﹤0.01% 1753
2025
Q3 		$104K Sell
63,377
-13,903
-18% -$15.5K ﹤0.01% 1764
2025
Q2 		$56.5K Buy
77,280
+2,260
+3% +$1.95K ﹤0.01% 1756
2025
Q1 		$60.5K Buy
75,020
+25,837
+53% +$29.7K ﹤0.01% 1537
2024
Q4 		$67.9K Buy
+49,183
New +$55.2K ﹤0.01% 1284

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

IEQ Capital's CHRS Position: Q1 2026 in Review

IEQ Capital increased its Coherus Oncology (CHRS) stake by 54% in Q1 2026, buying an estimated $76.1K and bringing the position to 121,967 shares worth $206K. The position accounts for ﹤0.01% of the portfolio, ranked #1690.

IEQ Capital first reported a position in CHRS in Q4 2024 and has held it in 6 quarters since. 157 funds tracked by Wall St. Rank hold CHRS as of Q1 2026.

  • IEQ Capital held 121,967 shares of Coherus Oncology worth $206K as of Q1 2026.
  • IEQ Capital bought 42,839 Coherus Oncology shares in Q1 2026, an estimated $76.1K.
  • Coherus Oncology made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1690 holding.
  • IEQ Capital first reported a position in Coherus Oncology in Q4 2024 and has held it in 6 quarters since.
  • 157 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.